While this was a pilot study, researchers said the findings showed clear differences between groups and provide early data that support larger trials testing the drugs as a therapy for people who want to reduce their alcohol use
However, the best management is still controversial in patients with recurrent MTC and distant metastases, because many patients with metastatic disease have indolent disease courses for a long time [1,4]
The Future of GLP-1 Medications in Weight Management Innovations in Delivery Methods As technology advances, new delivery methods for GLP-1 medications are emerging, enhancing patient convenience and compliance
A study published in November found that people with alcohol-use disorder who took a GLP-1 receptor agonist medication were less likely to be hospitalized for alcohol-related issues
Similarly, a possible SGLT2- i interfering effect on AGT/ANG II system together with intrarenal ANG II/AT2R pathways, especially when combined to RAAS blockers, can be argued